- Home
- TAK vs TEVA Comparison
TAK vs TEVA Comparison
Compare TAK & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | TEVA |
|---|---|---|
| Founded | 1781 | 1901 |
| Country | Japan | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.1B | 40.5B |
| IPO Year | 2007 | 1996 |
Fundamental Metrics
Financial Performance| Metric | TAK | TEVA |
|---|---|---|
| Price | $17.45 | $36.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $38.63 |
| AVG Volume (30 Days) | 4.0M | ★ 5.3M |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | N/A | ★ 183.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.16 | N/A |
| Revenue Next Year | $1.22 | $2.97 |
| P/E Ratio | $41.25 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.99 | $17.33 |
| 52 Week High | $18.90 | $37.35 |
Technical Indicators
Market Signals| Indicator | TAK | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 58.40 | 68.69 |
| Support Level | $16.15 | $30.42 |
| Resistance Level | $17.83 | $37.17 |
| Average True Range (ATR) | 0.25 | 1.00 |
| MACD | 0.00 | 0.41 |
| Stochastic Oscillator | 73.86 | 92.61 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.